Clinical trial Recruiting at 1 site Observational

Do cortisol changes after gastric bypass or sleeve cause reactive low blood sugar?

Official title: Cortisol and Obesity - A Vicious Cycle? Hypoglycemia After Bariatric Surgery - Association With Cortisol Metabolism?

Run by Esbjerg Hospital - University Hospital of Southern Denmark · NCT06896682 · Data updated 2026-11-12

This project will see if cortisol changes after gastric bypass or sleeve surgery are linked to reactive low blood sugar in adults who had surgery at least 12 months ago.

More Postbariatric Hypoglycemia trials

Quick facts

Study typeObservational
SexAll
Enrollment100 (estimated)
SponsorEsbjerg Hospital - University Hospital of Southern Denmark
Academic / other
Locations1 site (Esbjerg)
StatusRecruiting
StartedJuly 8, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedMarch 13, 2026
Trial IDNCT06896682 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults who had Roux-en-Y gastric bypass or sleeve at least 12 months ago, who are not pregnant or breastfeeding and who are not taking excluded medications or have excluded medical conditions, are ideal candidates.

Probably not a fit

People who are pregnant or breastfeeding, have known adrenal disease, nephrotic syndrome, liver cirrhosis, severe malnutrition, are on corticosteroids, opioid-containing medications, estrogen therapy, or already have medically treated postbariatric hypoglycemia are unlikely to benefit from participating.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project will enroll about 100 people who underwent Roux-en-Y gastric bypass or sleeve at least one year earlier. Participants attend two visits at Esbjerg Hospital with blood draws and an ACTH adrenal stimulation test, wear a continuous glucose monitor for around ten days, and provide 24-hour urine collections and saliva samples if hypoglycemia symptoms occur. The study compares cortisol production and metabolism measures with continuous glucose patterns and reported symptoms to determine whether altered cortisol handling contributes to postbariatric reactive hypoglycemia. No treatments are administered; the protocol is focused on diagnostic testing and monitoring.

Why it matters

Potential benefit: If successful, the results could identify hormonal causes of postbariatric reactive hypoglycemia and suggest new ways to prevent or treat it.

How similar studies have gone: Some prior studies have measured cortisol changes after bariatric surgery, but few have directly linked cortisol metabolism to postbariatric reactive hypoglycemia, so this approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Participants must have undergone one of the following bariatric procedures at least 12 months prior:

* Roux-en-Y gastric bypass
* Gastric sleeve

Exclusion Criteria

* Pregnancy and breastfeeding
* Nephrotic syndrome (kidney disease with protein loss in urine), liver cirrhosis, or severe malnutrition, as these conditions reduce cortisol-binding globulin (CBG) levels, affecting total cortisol concentration
* Use of corticosteroid medications, such as prednisolone
* Use of opiod-containing medication
* Use of medications containing estrogen, such as hormone therapy for menopause
* Known adrenal disease affecting cortisol metabolism, including autonomous cortisol production and Cushing's syndrome
* Diabetes that does not require medical treatment
* Previously diagnosed reactive hypoglycemia after bariatric surgery requiring medical treatment

Where it's running

  • Esbjerg Hospital
    Esbjerg, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Mizagliflozin for post-bariatric hypoglycemia

    This study tests Mizagliflozin to see if it can reduce hypoglycemia in adults who had Roux-en-Y bariatric surgery and experience reactive hypoglycemia.

    Recruiting at 3 sites Phase 2 Vogenx, Inc. · Chula Vista, California and 10 other locations · NCT07760961

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.